BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38254749)

  • 21. The use of near-infrared autofluorescence during total laryngectomy with hemi- or total thyroidectomy.
    Barbieri D; Melegatti MN; Vinciguerra A; Indelicato P; Giordano L; Bondi S; Biafora M; Trimarchi M; Bussi M
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):365-371. PubMed ID: 35920893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single inferior parathyroid autotransplantation during total thyroidectomy with bilateral central lymph node dissection for papillary thyroid carcinoma: a retrospective cohort study.
    Dong Z; Liu W; Peng Y; Zhan X; Su Y; Diao C; Cheng R
    World J Surg Oncol; 2023 Mar; 21(1):102. PubMed ID: 36959661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraoperative Autofluorescence Imaging for Parathyroid Gland Identification during Total Laryngectomy with Thyroidectomy.
    Obongo Anga R; Abbaci M; Guerlain J; Breuskin I; Casiraghi O; Marhic A; Benmoussa-Rebibo N; de Kermadec H; Moya-Plana A; Temam S; Gorphe P; Hartl DM
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of active localization and vascular preservation of inferior parathyroid glands in central neck dissection for papillary thyroid carcinoma.
    Hou D; Xu H; Yuan B; Liu J; Lu Y; Liu M; Qian Z
    World J Surg Oncol; 2020 May; 18(1):95. PubMed ID: 32404116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Carbon Nanoparticle Lymphatic Tracer Protected Parathyroid Glands During Radical Thyroidectomy for Papillary Thyroid Non-Microcarcinoma.
    Long M; Luo D; Diao F; Huang M; Huang K; Peng X; Lin S; Li H
    Surg Innov; 2017 Feb; 24(1):29-34. PubMed ID: 27634477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of hypoparathyroidism after central compartment lymph node dissection in the surgical treatment of pT1, N0 thyroid papillary carcinoma.
    Aydin OU; Soylu L; Ozbas S; Ilgan S; Bilezikci B; Gursoy A; Sengezer T; Kocak S
    Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1781-7. PubMed ID: 27212170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Indocyanine Green Fluorescence During Total Thyroidectomy to Identify Parathyroid Glands and Prevent Hypoparathyroidism.
    Zhang D; Sun H; Frattini F; Kim HY; Wu CW; Donatini G; Cestari A; Bertoli S; Barbieri D; Bussi M; Dionigi G
    Surg Technol Int; 2023 Dec; 43():. PubMed ID: 38237113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application of carbon nano-particles in total thyroidectomy combined with lymphadenectomy in area Ⅵ].
    Qian YC; Liu FZ; Yao WP; Zhao YB; Jiang Y; Zhang Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):28-32. PubMed ID: 30704166
    [No Abstract]   [Full Text] [Related]  

  • 29. Papillary thyroid cancer: controversies in the management of neck metastasis.
    Davidson HC; Park BJ; Johnson JT
    Laryngoscope; 2008 Dec; 118(12):2161-5. PubMed ID: 19029855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-thyroidectomy hypoparathyroidism, what should we keep in mind?
    Caglià P; Puglisi S; Buffone A; Bianco SL; Okatyeva V; Veroux M; Cannizzaro MA
    Ann Ital Chir; 2017; 6():371-381. PubMed ID: 29197191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The most reliable time point for intact parathyroid hormone measurement to predict hypoparathyroidism after total thyroidectomy with central neck dissection to treat papillary thyroid carcinoma: a prospective cohort study.
    Chang JW; Park KW; Jung SN; Liu L; Kim SM; Koo BS
    Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):549-558. PubMed ID: 31620890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors of permanent hypoparathyroidism after total thyroidectomy and central neck dissection for papillary thyroid cancer: a prospective study.
    Godlewska P; Benke M; Stachlewska-Nasfeter E; Gałczyński J; Puła B; Dedecjus M
    Endokrynol Pol; 2020; 71(2):126-133. PubMed ID: 32154569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery.
    Conzo G; Mauriello C; Docimo G; Gambardella C; Thomas G; Cavallo F; Tartaglia E; Napolitano S; Varriale R; Rossetti G; Fei L; Santini L
    Int J Surg; 2014; 12 Suppl 1():S194-7. PubMed ID: 24862675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Level VII is an important component of central neck dissection for papillary thyroid cancer.
    Wang LY; Versnick MA; Gill AJ; Lee JC; Sidhu SB; Sywak MS; Delbridge LW
    Ann Surg Oncol; 2013 Jul; 20(7):2261-5. PubMed ID: 23361896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elective Central Compartment Lymph Node Dissection Does not Increase the Risk of Postoperative Hypoparathyroidism in Patients Treated for Differentiated Thyroid Cancer.
    Stubljar B; Pastorčić Grgić M; Mayer L; Perše P; Tomičević T
    Acta Clin Croat; 2020 Jun; 59(Suppl 1):115-121. PubMed ID: 34219893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma.
    Pereira JA; Jimeno J; Miquel J; Iglesias M; Munné A; Sancho JJ; Sitges-Serra A
    Surgery; 2005 Dec; 138(6):1095-100, discussion 1100-1. PubMed ID: 16360396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of intraoperative autofluorescence monitoring on unintentional parathyroid gland excision rates and postoperative PTH concentrations-a single-blind randomized-controlled trial.
    Papavramidis TS; Chorti A; Tzikos G; Anagnostis P; Pantelidis P; Pliakos I; Panidis S; Papaioannou M; Bakkar S; Unal E; Michalopoulos A
    Endocrine; 2021 May; 72(2):546-552. PubMed ID: 33432503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total thyroidectomy without prophylactic central neck dissection in clinically node-negative papillary thyroid cancer: is it an adequate treatment?
    Calò PG; Pisano G; Medas F; Marcialis J; Gordini L; Erdas E; Nicolosi A
    World J Surg Oncol; 2014 May; 12():152. PubMed ID: 24885654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preserving Parathyroid Gland Vasculature to Reduce Post-thyroidectomy Hypocalcemia.
    Park I; Rhu J; Woo JW; Choi JH; Kim JS; Kim JH
    World J Surg; 2016 Jun; 40(6):1382-9. PubMed ID: 27028753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of Autofluorescence for Parathyroid Glands During Thyroid Surgery and the Risk of Hypocalcemia: First Results in Belgium and Review of the Literature.
    Van Slycke S; Van Den Heede K; Brusselaers N; Vermeersch H
    Surg Innov; 2021 Aug; 28(4):409-418. PubMed ID: 33372584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.